Neotherix has been invited to take part in the forthcoming Future Health Mission 2011 to San Francisco and Silicon Valley in January 2011. The mission, supported by the Technology Strategy Board and UK Trade and Investment, will allow the selected group of 20 innovative and high growth potential companies to establish contacts with investors, potential partners and customers in the US. The mission will be aligned to the JP Morgan Healthcare Conference which will provide opportunities to explore the global marketplace and gain insights from US entrepreneurs. Neotherix will be communicating progress made in its EktoTherix™ programme as well as introducing other product developments arising from its regenerative tissue scaffold technology.
Links to the Technology Strategy Board press release and the Future Health Mission 2011 web site .